Journals / İstanbul Medical Journal / 2019 / Cilt: 20 - Sayı: 5

MTHFR C677T and A1298C Gene Polymorphisms in Human Kidney Cancer Tissues

İnsan Böbrek Kanseri Dokularında MTHFR C677T ve A1298C Gen Polimorfizmleri

Pages
408–412
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Odds ratio of MTHFR C677T CC genotype was found 1.8 compared to CT genotype (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The potential effect of 5,10- methylenetetrahydrofolate reductase (MTHFR) on DNA methylation, DNA repair and DNA synthesis has made MTHFR a cancer-inducing gene.
📊
Key Findings & Data:In this study, we aimed to evaluate C677T and A1298C gene polymorphisms in kidney cancer.
💡
Conclusion & Impact:Odds ratio of MTHFR C677T CC genotype was found 1.8 compared to CT genotype (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The potential effect of 5,10- methylenetetrahydrofolate reductase (MTHFR) on DNA methylation, DNA repair and DNA synthesis has made MTHFR a cancer-inducing gene. In this study, we aimed to evaluate C677T and A1298C gene polymorphisms in kidney cancer. Methods: During the normal treatment procedure, 100 tumor and 100 surrounding healthy kidney tissue samples were obtained from patients after surgery. DNA was isolated from the tissues by DNA Isolation kit. Polymerase chain reaction andrestriction fragment length polymorphism methods were used. Genotype and allele distributions were analyzed using SPSS 22 and p0.05). MTHFRC677T CC genotype (51%) was found to be higher in kidney cancer tissues than CT genotype (34%). Odds ratio of MTHFR C677T CC genotype was found 1.8 compared to CT genotype (p

Özet

Amaç: 5,10-metilenetetrahidrofolat redüktaz’ın (MTHFR) DNA metilasyonu, DNA onarımı ve DNA sentezi üzerindeki potansiyel etkisi MTHFR’yi kanseri indükleyen bir gen yapmıştır. Çalışmamızda böbrek kanserinde C677T ve A1298C gen polimorfizmlerini değerlendirmeyi amaçladık. Yöntemler: Normal tedavi prosedürü sırasında cerrahi operasyon sonrası hastalardan 100 tümör ve 100 sağlıklı çevre böbrek dokusu örneği alındı. DNA izolasyon kiti ile dokulardan DNA izole edildi. Polimeraz zincir reaksiyonu ve restriksiyon fragman uzunluğu polimorfizmi yöntemi uygulandı. Genotip ve allel dağılımları SPSS 22 ile analiz edildi ve p0,05). Böbrek kanserli dokularda MTHFR C677T CC genotipinin (%51) CT genotipine (%34) oranla daha fazla olduğu bulundu. MTHFR C677T CC genotipinin CT genotipine oranla elde edilen tahmini rölatif riski 1,8 olarak belirlendi (p

🔖

Cite This Article

ÖTÜNÇTEMUR, A., PENÇE, H. H., PENÇE, S., ÇAYKARA, B., ALSAADONI, H. (2022). MTHFR C677T and A1298C Gene Polymorphisms in Human Kidney Cancer Tissues. İstanbul Medical Journal, Cilt: 20 - Sayı: 5, 408–412. https://ajindex.com/articles/551903

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917
  2. Novick AC, Campbell SC, Retik AB, Vaughan ED, Wein AJ, Kavoussi LR, et al. In: Renal Tumors. Campbell’s Urology. 8th edition. New York: WB Saunders Co Ltd 2002. 2672-731
  3. Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: A metabolic disease. Nature Rev Urol 2010; 7: 277-85
  4. Martinez CV. The effect of the interaction folate - MTHFR 677 C>T Mutation on DNA Integrity and Gene Expression, Ph. Doctora Thesis, Friedman School of Nutrition Science and Policy, Tufts University 2006
  5. Taşçıoğlu N. Gastrointestinal sistem kanserlerinde metilentetrahidrofolat redüktaz geni 677 C≈T, 1298 A≈C ve Metiyonin 99 Sentetaz Geni 2756 A≈G polimorfizmlerinin incelenmesi, yüksek lisans tezi, Erciyes Üniversitesi Sağlık Bilimleri Enstitüsü Tıbbi Biyoloji Anabilim Dalı, Kayseri 2005
  6. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. “Methylenetetrahydrofolate reductase, diet, and risk of colon cancer”, Cancer Epidemiology 1999; 8: 513-8
  7. Leopardi P, Marcon F, Caiola S, Cafolla A, Siniscalchi E, Zijno A, et al. “Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes”, Mutagenesis 2006; 21: 327-33
  8. Al-Motassem Y, Shomaf M, Said I, Berger S, Ababneh N, Diab O, et al. Allele and genotype frequencies of the polymorphic methylenetetrahydrofolate reductase and lung cancer in ther jordanian population: A case control study. Asian Pac J Cancer Prev. 2015; 16: 3101-9
  9. Zhu B, Wu X, Zhi X, Liu L, Zheng Q, Sun G. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies. PLoS One 2014; 9: e102443
  10. Trovato FM, Catalano D, Ragusa A, Martines GF, Pirri C, Buccheri MA, et al. Relationship of MTHFR gene polymorphisms with renal and cardiac disease. World J Nephrol 2015; 4: 127-37
  11. Hou X, Chen X, Shi J. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis. Gene 2015; 565: 39- 44
  12. Mehlig K, Leander K, de Faire U, Nyberg F, Berg C, Rosengren A, et al. The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism. Heart 2013; 99: 1761-5
  13. Födinger M, Hörl WH, Sunder-Plassmann G. Molecular biology of 5,10-